Article
Alternatively activated dendritic cells derived from systemic lupus erythematosus patients have tolerogenic phenotype and function.
Clinical immunology (Orlando, Fla.) - 1 Jan 2015
Wu Hai Jing, Lo Yi, Luk Daniel, Lau Chak Sing, Lu Liwei, Mok Mo Yin
Abstract excerpt
Tolerogenic dendritic cells (DCs) are potential cell-based therapy in autoimmune diseases. In this study, we generated alternatively activated DCs (aaDCs) by treating monocyte-derived DCs from patients with systemic lupus erythematosus (SLE) and healthy subjects with combination of 1,25 dihydroxyvitamin D(3) (vitD3) and dexamethasone followed by lipopolysaccharide-induced maturation. Lupus aaDCs were found to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
